This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
Clinical significance of free-to-total prostate-specific antigen (PSA) ratio in advanced prostate cancer patients with PSA less than 0.1 ng/ml after hormone treatment - Abstract
May 25, 2012
Algorithm for selecting men for pelvic lymph node dissection (PLND) during radical prostatectomy based on clinical risk factors in an Australian population - Abstract
May 25, 2012
Advanced prostate cancer: Treatment and patient-centred care - Abstract
May 25, 2012
Annual prostatectomy volume is related to rectal laceration rate after radical prostatectomy - Abstract
May 25, 2012
ACR Appropriateness Criteria® external-beam radiation therapy treatment planning for clinically localized prostate cancer - Abstract
May 25, 2012
Prostate weight is the preferred measure of prostate size in radical prostatectomy cohorts - Abstract
May 25, 2012
Active surveillance for prostate cancer: An Australian experience - Abstract
May 25, 2012
In situ and intraductal epithelial proliferations of prostate: Definitions and treatment implications. Part 1: Prostatic intraepithelial neoplasia - Abstract
May 25, 2012
Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI - Abstract
May 25, 2012
Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer - Abstract
May 25, 2012
Detecting prostate cancer with MRI - why and how - Abstract
May 25, 2012
Endocrine prevention and treatment of prostate cancer - Abstract
May 25, 2012
Imaging techniques for local recurrence of prostate cancer: For whom, why and how? - Abstract
May 25, 2012
Phase I/II trial of single-fraction high-dose-rate brachytherapy-boosted hypofractionated intensity-modulated radiation therapy for localized adenocarcinoma of the prostate - Abstract
May 25, 2012
AUA 2012 - The association between male pattern baldness and second to fourth finger ratio with prostate cancer - a prospective cohort study - Press Briefing
May 24, 2012
Validation in Spain of the Quality of Life Questionnaire PROSQOLI in patients with advanced prostate cancer - Abstract
May 24, 2012
Healthcare resource use in advanced prostate cancer patients treated with docetaxel - Abstract
May 24, 2012
Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: Report from a Consensus Panel - Abstract
May 24, 2012
Beyond PSA: The next generation of prostate cancer biomarkers - Abstract
May 24, 2012
AUA 2012 - Genetic variants associated with severity of lower urinary tract symptoms and prostate cancer susceptibility - Press Release
May 24, 2012
Page 1298 of 1444
Start
Prev
1293
1294
1295
1296
1297
1298
1299
1300
1301
1302
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free